SCHEMBL4936895

SCHEMBL4936895

N=C(N)NC(=O)c1ccc(-c2cccc(N)c2)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
MAPT P10636 4/20 0.50
GAA P10253 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SLC9A1 P19634 5/20 0.44
S1PR4 O95977 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NR4A3 Q92570 1/20 0.43
PRSS1 P07477 1/20 0.41
TMPRSS15 P98073 1/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 2/20 0.40
USP2 O75604 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4936806 0.85 SLC9A1 (0.61) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL4943798 0.85 SLC9A1 (0.61) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL4943698 0.83 LMNA (0.51) ALDH1A1KDM4EMAPTSLC9A1PRSS1
SCHEMBL4941158 0.81 ALDH1A1 (0.74) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL28747774 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL1913707 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL4943637 0.81 SLC9A1 (0.58) ALDH1A1KDM4EMAPTGAASLC9A1
SCHEMBL4937176 0.80 SLC9A1 (0.59) ALDH1A1KDM4EMAPTGAAL3MBTL1
SCHEMBL4944299 0.78 S1PR4 (0.51) ALDH1A1KDM4EMAPTGAASLC9A1
SCHEMBL4532675 0.78 NR4A1 (0.67) ALDH1A1KDM4EMAPTGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 ALDH1A1 297/4885KDM4E 3451/4885MAPT 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.